Form 8-K - Current report:
SEC Accession No. 0001576280-25-000269
Filing Date
2025-09-24
Accepted
2025-09-24 07:50:17
Documents
12
Period of Report
2025-09-24
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K gh-20250924.htm   iXBRL 8-K 27291
  Complete submission text file 0001576280-25-000269.txt   142971

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20250924.xsd EX-101.SCH 1882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20250924_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20250924_pre.xml EX-101.PRE 12605
14 EXTRACTED XBRL INSTANCE DOCUMENT gh-20250924_htm.xml XML 2798
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 251335189
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)